Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
OGN Organon & Co
- Stocks
- Healthcare
- NYSE: OGN
Price (delayed)
$9.63
Market cap
$2.5B
P/E Ratio
3.31
Dividend/share
$0.86
EPS
$2.91
Enterprise value
$10.91B
Highlights
The price to earnings (P/E) is 43% less than the 5-year quarterly average of 5.8 and 30% less than the last 4 quarters average of 4.7
The equity is up by 15% QoQ
The quick ratio has contracted by 7% YoY but it has grown by 2.7% from the previous quarter
The company's EPS fell by 29% YoY and by 13% QoQ
Organon's net income has decreased by 28% YoY and by 13% from the previous quarter
Key stats
What are the main financial stats of OGN
Market
Valuations
Earnings
Shares outstanding
259.96M
Market cap
$2.5B
Enterprise value
$10.91B
Price to earnings (P/E)
3.31
Price to book (P/B)
4.58
Price to sales (P/S)
0.39
EV/EBIT
9.21
EV/EBITDA
7.37
EV/Sales
1.73
Revenue
$6.29B
Gross profit
$3.6B
Operating income
$1.23B
Net income
$750M
EBIT
$1.19B
EBITDA
$1.48B
Free cash flow
$781M
Per share
Balance sheet
Liquidity
EPS
$2.91
EPS diluted
$2.87
Free cash flow per share
$3.03
Book value per share
$2.1
Revenue per share
$24.41
TBVPS
$27.38
Total assets
$13.16B
Total liabilities
$12.61B
Debt
$8.96B
Equity
$542M
Working capital
$1.76B
Debt to equity
16.52
Current ratio
1.67
Quick ratio
0.77
Net debt/EBITDA
5.68
Margins
Efficiency
Dividend
EBITDA margin
23.5%
Gross margin
57.2%
Net margin
11.9%
Operating margin
19.6%
Return on assets
5.9%
Return on equity
181.7%
Return on invested capital
9.5%
Return on capital employed
11.2%
Return on sales
18.8%
Dividend yield
8.93%
DPS
$0.86
Payout ratio
29.6%
OGN stock price
How has the Organon stock price performed over time
Intraday
0.73%
1 week
-2.83%
1 month
-5.5%
1 year
-53.72%
YTD
-35.46%
QTD
-0.52%
Financial performance
How have Organon's revenue and profit performed over time
Revenue
$6.29B
Gross profit
$3.6B
Operating income
$1.23B
Net income
$750M
Gross margin
57.2%
Net margin
11.9%
Organon's net margin has decreased by 28% YoY and by 12% from the previous quarter
Organon's net income has decreased by 28% YoY and by 13% from the previous quarter
The company's operating income fell by 10% QoQ
OGN's operating margin is down by 9% since the previous quarter
Price vs fundamentals
How does OGN's price correlate with its fundamentals
Growth
What is Organon's growth rate over time
Valuation
What is Organon stock price valuation
P/E
3.31
P/B
4.58
P/S
0.39
EV/EBIT
9.21
EV/EBITDA
7.37
EV/Sales
1.73
The price to earnings (P/E) is 43% less than the 5-year quarterly average of 5.8 and 30% less than the last 4 quarters average of 4.7
The company's EPS fell by 29% YoY and by 13% QoQ
The P/B is 70% less than the last 4 quarters average of 15.5
The equity is up by 15% QoQ
The price to sales (P/S) is 61% lower than the 5-year quarterly average of 1.0 and 44% lower than the last 4 quarters average of 0.7
Efficiency
How efficient is Organon business performance
The return on equity has declined by 39% since the previous quarter
The ROA has declined by 35% year-on-year and by 14% since the previous quarter
The return on invested capital has declined by 12% since the previous quarter and by 6% year-on-year
The company's return on sales fell by 9% QoQ
Dividends
What is OGN's dividend history
DPS
$0.86
Dividend yield
8.93%
Payout ratio
29.6%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Organon financials performed over time
OGN's total assets is 4.3% more than its total liabilities
OGN's total assets is up by 11% YoY
The quick ratio has contracted by 7% YoY but it has grown by 2.7% from the previous quarter
The debt to equity has plunged by 91% YoY and by 12% from the previous quarter
The equity is up by 15% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.